NR AHOQ
AU Ludlam,C.A.
TI New-variant Creutzfeldt-Jakob disease and treatment of haemophilia. Executive Committee UK Haemophilia Directors' Organisation.
QU Lancet 1998 Apr 25; 351(9111): 1289-90
KZ Lancet. 1998 Feb 21;351(9102):600-1. PMID: 9492811
PT comment; letter
MH Creutzfeldt-Jakob Syndrome/*transmission; Factor VIII/adverse effects/therapeutic use; Hemophilia A/*therapy; Human; Recombinant Proteins/therapeutic use; Risk Factors
SP englisch
PO England